Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial

NCT04939311 is registered in ClinicalTrials.gov with Priscilla Hsue, MD as lead sponsor.

NCT NCT04939311
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04939311 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunomodulation Using VB-201 to Reduce Arterial Inflammation in Treated HIV - VITAL HIV Trial
Lead sponsor
Priscilla Hsue, MD
Phase
Phase 1/2
Overall status
Withdrawn
Start date
July 1, 2022
Completion date
July 1, 2027
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular disease, hiv infection, inflammation